Recent advances in the prevention and treatment of skin cancer using photodynamic therapy
暂无分享,去创建一个
[1] Jarod C Finlay,et al. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. , 2005, Journal of photochemistry and photobiology. B, Biology.
[2] Cynthia C. Morton,et al. Intraindividual, right–left comparison of topical methyl aminolaevulinate‐photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study , 2006, The British journal of dermatology.
[3] P. Karran,et al. Treatment of post‐transplant premalignant skin disease: a randomized intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy , 2007, The British journal of dermatology.
[4] Qian Peng,et al. An outline of the hundred-year history of PDT. , 2003, Anticancer research.
[5] J. Moan,et al. On the diffusion length of singlet oxygen in cells and tissues , 1990 .
[6] Xiuli Wang,et al. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience. , 2008, Photodiagnosis and photodynamic therapy.
[7] J. Nelson,et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.
[8] P. Collins,et al. Randomized, double‐blind, placebo‐controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5‐aminolaevulinic acid–photodynamic therapy for extensive scalp actinic keratoses , 2006, The British journal of dermatology.
[9] N. Pimpinelli,et al. Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. , 2006, Journal of the American Academy of Dermatology.
[10] D. Kessel,et al. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. , 1998, Journal of Investigative Dermatology.
[11] M. Bulsara,et al. Cold Air Analgesia in Photodynamic Therapy of Basal Cell Carcinomas and Bowen's Disease: An Effective Addition to Treatment A Pilot Study , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[12] F. Moloney,et al. Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.
[13] F. Prignano,et al. Topical 5-Aminolevulinic Acid and Photodynamic Therapy in Dermatology: a Minireview , 2001, Journal of chemotherapy.
[14] Zheng Huang,et al. Combination of immunotherapy and photodynamic therapy in the treatment of Bowenoid papulosis. , 2007, Photodiagnosis and photodynamic therapy.
[15] H. Wulf,et al. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. , 2006, Acta dermato-venereologica.
[16] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[17] A. Tedesco,et al. Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. , 2007, Photomedicine and laser surgery.
[18] K. Giercksky,et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.
[19] G. Stables,et al. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy. , 2005, Journal of the American Academy of Dermatology.
[20] C. Morton,et al. Topical 5‐ALA photodynamic therapy for the treatment of cutaneous T‐cell lymphoma , 2002, Clinical and experimental dermatology.
[21] H. Barr,et al. The potential role for photodynamic therapy in the management of upper gastrointestinal disease , 2001, Alimentary pharmacology & therapeutics.
[22] T. Ruzicka,et al. Successful Surgery of Multiple Recurrent Basal Cell Carcinomas Guided by Photodynamic Diagnosis , 1997, Aesthetic Plastic Surgery.
[23] Yong Zhang,et al. Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.
[24] N. Bendsoe,et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.
[25] T. Fitzpatrick,et al. Part IV: Basic Considerations of the Psoralens: Historical Aspects of Methoxsalen and Other Furocoumarins1 , 1959 .
[26] P. Yamauchi,et al. Topical photodynamic therapy in clinical dermatology , 2004, The British journal of dermatology.
[27] V. Bagnato,et al. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa , 2005, The British journal of dermatology.
[28] J. Sessler,et al. Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.
[29] H. C. de Vijlder,et al. Liposomes in dermatology today , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[30] S. Gollnick,et al. Enhancement of anti-tumor immunity by photodynamic therapy , 2010, Immunologic research.
[31] Mary N. Phan,et al. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment , 2005 .
[32] R. Sinclair,et al. Photodynamic therapy for subungual Bowen's disease , 2004, The Australasian journal of dermatology.
[33] Marcel Garcia,et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. , 2009, Chemical communications.
[34] T. Delaney,et al. Photodynamic therapy of cancer. , 1988, Comprehensive therapy.
[35] M. Olivo,et al. ART AND SCIENCE OF PHOTODYNAMIC THERAPY , 2006, Clinical and experimental pharmacology & physiology.
[36] R. Wolterbeek,et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. , 2006, The Journal of investigative dermatology.
[37] C. Morton,et al. Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.
[38] H. Kosmehl,et al. Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients , 2004, Journal of Cancer Research and Clinical Oncology.
[39] Menno A de Rie,et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. , 2007, Archives of dermatology.
[40] P. Wolf,et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. , 2006, Archives of dermatology.
[41] R. Gurny,et al. State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.
[42] Indrajit Roy,et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.
[43] H. Lui,et al. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet‐induced skin tumours in mice , 2001, The British journal of dermatology.
[44] A. Wennberg,et al. In vivo detection of basal cell carcinoma using imaging spectroscopy. , 1999, Acta dermato-venereologica.
[45] R. Dummer,et al. Photodynamic Therapy – a New Treatment Option for Epithelial Malignancies of the Skin , 2004, Oncology Research and Treatment.
[46] J Moan,et al. PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH , 1992, Photochemistry and photobiology.
[47] Photodynamic Therapy with Verteporfin in Age-related Macular Degeneration , 2006 .
[48] T. Fitzpatrick,et al. Historical aspects of methoxsalen and other furocoumarins. , 1959, The Journal of investigative dermatology.
[49] François Guillemin,et al. Nanoparticles as vehicles for delivery of photodynamic therapy agents. , 2008, Trends in biotechnology.
[50] A. Oseroff,et al. PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. , 2006, The Journal of investigative dermatology.
[51] U. Schmidt-Erfurth,et al. Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. , 2000, Survey of ophthalmology.
[52] Baowei Fei,et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.
[53] D. Robinson,et al. Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme. , 2007, Archives of dermatology.
[54] A. Oseroff,et al. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. , 2003, Molecular immunology.
[55] A. Hauschild,et al. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self‐adhesive 5‐aminolaevulinic acid patch , 2009, Experimental dermatology.
[56] G. Palumbo. Photodynamic therapy and cancer: a brief sightseeing tour , 2007, Expert opinion on drug delivery.
[57] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[58] C. Morton. Methyl aminolevulinate (Metvix®) photodynamic therapy - practical pearls , 2003, The Journal of dermatological treatment.
[59] C. Morton. Photodynamic therapy for nonmelanoma skin cancer--and more? , 2004, Archives of dermatology.
[60] A. Bosserhoff,et al. Recent progress in understanding the pathology of malignant melanoma , 2009, The Journal of pathology.
[61] H Moseley,et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.
[62] M. Landthaler,et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. , 1996, Dermatology.
[63] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[64] R. Dawber,et al. Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions , 1998, The Australasian journal of dermatology.
[65] K. Cooper,et al. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer , 2005, Expert review of anticancer therapy.
[66] N. Nishikawa,et al. Cyclooxygenase‐2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity , 2004, The British journal of dermatology.
[67] Zahi A Fayad,et al. Nanotechnology in Medical Imaging: Probe Design and Applications , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[68] H. Wulf,et al. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home‐based daylight exposure: a double‐blinded randomized clinical trial , 2009, The British journal of dermatology.
[69] Kai Chen,et al. Role of the c-Jun N-terminal kinase signaling pathway in SW480 cell apoptosis in response to 5-aminolevulinic acid-based photodynamic therapy , 2008 .
[70] C. Foote. DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATION , 1991, Photochemistry and photobiology.
[71] S. Ibbotson,et al. A randomized, double‐blind, placebo‐controlled study of the efficacy of tetracaine gel (Ametop®) for pain relief during topical photodynamic therapy , 2004, The British journal of dermatology.
[72] J. Paoli,et al. Penile intraepithelial neoplasia: results of photodynamic therapy. , 2006, Acta dermato-venereologica.
[73] H Stepp,et al. Photodetection of cervical intraepithelial neoplasia using 5‐aminolevulinic acid–induced porphyrin fluorescence , 2000, Cancer.
[74] D. Doiron,et al. Photodynamic Therapy for Nonmelanoma Skin Cancer , 1989, Facial plastic surgery : FPS.
[75] P. Lehmann. Methyl aminolaevulinate–photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer , 2007, The British journal of dermatology.
[76] Brett M. Coldiron,et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. , 2010, Archives of dermatology.
[77] R. Dummer,et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients , 2004, Transplantation.
[78] Yu-Ying He,et al. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. , 2009, Toxicology and applied pharmacology.
[79] T. Dougherty,et al. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. , 1996, Journal of clinical laser medicine & surgery.
[80] H. Pfister,et al. Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. , 2000, The Journal of investigative dermatology.
[81] R. Boyle,et al. Photodynamic therapy: novel third‐generation photosensitizers one step closer? , 2008, British journal of pharmacology.
[82] D. Murrell,et al. Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult‐to‐treat’ basal cell carcinoma , 2005, The British journal of dermatology.
[83] D. Leffell,et al. Management of nonmelanoma skin cancer in 2007 , 2007, Nature Clinical Practice Oncology.
[84] M. Cooney,et al. History of photodynamic therapy. , 1999, International ophthalmology clinics.
[85] H. Wulf,et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment , 2003, The British journal of dermatology.
[86] C P Lowdell,et al. Photodynamic therapy: an update. , 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).
[87] A. Cruz,et al. Aggravation of eyelid and conjunctival malignancies following photodynamic therapy in DeSanctis-Cacchione syndrome. , 2006, Ophthalmic Plastic and Reconstructive Surgery.
[88] CLAUDE C. FRAZIER,et al. PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.
[89] Satoko Kawauchi,et al. Supramolecular nanocarrier of anionic dendrimer porphyrins with cationic block copolymers modified with polyethylene glycol to enhance intracellular photodynamic efficacy. , 2005, Angewandte Chemie.
[90] Michael R Lee,et al. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy , 2005, The Australasian journal of dermatology.
[91] T. Sutedja,et al. Photodynamic therapy in lung cancer. A review. , 1996, Journal of photochemistry and photobiology. B, Biology.
[92] S. Lam. Photodynamic therapy of lung cancer. , 1993, Thorax.
[93] R. Dummer,et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients , 2004, The British journal of dermatology.
[94] A. Anstey,et al. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale , 2000, The British journal of dermatology.
[95] L. Singerman,et al. Recent advances in the management of age-related macular degeneration. , 2002, Optometry and vision science : official publication of the American Academy of Optometry.
[96] C. Hinton,et al. Bowen's disease of the nipple-a new method of treatment. , 2005, Breast.
[97] Wei Zheng,et al. The use of digitized endoscopic imaging of 5‐ALA‐induced PPIX fluorescence to detect and diagnose oral premalignant and malignant lesions in vivo , 2004, International journal of cancer.
[98] F. Tseng,et al. Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics , 2009 .
[99] P. von den Driesch,et al. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. , 2004, Journal of the American Academy of Dermatology.
[100] R. Ceilley,et al. Current modalities and new advances in the treatment of basal cell carcinoma , 2006, International journal of dermatology.
[101] P. Jichlinski. Photodynamic applications in superficial bladder cancer: facts and hopes! , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.
[102] R. Botella-Estrada,et al. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5‐aminolaevulinic acid , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.
[103] Jon Evans,et al. High-tech bandages lighten the load of light therapy. , 2009 .
[104] Thomas J. Flotte,et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment , 2004, Archives of Dermatological Research.
[105] M. Olivo,et al. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models , 2005, Cancer Chemotherapy and Pharmacology.
[106] A. Oseroff,et al. Aminolevulinic acid photodynamic therapy for skin cancers. , 2007, Dermatologic clinics.
[107] M. Landthaler,et al. Photodynamic therapy in dermatology – an update , 2005, Photodermatology, photoimmunology & photomedicine.
[108] Robinson,et al. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.
[109] L. Kemény,et al. Skin cancers after organ transplantation. , 2003, The New England journal of medicine.
[110] R. Bissonnette. Chemopreventative thoughts for photodynamic therapy. , 2007, Dermatologic clinics.
[111] T Poulsen,et al. Photodynamic Therapy with Topical dL‐aminolevulinic Acid Delays UV Photocarcinogenesis in Hairless Mice , 1997, Photochemistry and photobiology.
[112] M. Thissen,et al. SHORT COMMUNICATIONPhotodynamic therapy with delta‐aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique , 2000, The British journal of dermatology.
[113] R. Szeimies. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma. , 2007, Dermatologic clinics.
[114] Q. Peng,et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.
[115] Carin Sandberg,et al. Fluorescence contrast and threshold limit: implications for photodynamic diagnosis of basal cell carcinoma. , 2003, Journal of photochemistry and photobiology. B, Biology.
[116] P. Calzavara-Pinton,et al. Photodynamic therapy: update 2006 Part 1: Photochemistry and photobiology , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[117] G. Rennie,et al. MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.
[118] R. Sala,et al. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T‐cell lymphoma , 2006, Photodermatology, photoimmunology & photomedicine.
[119] R. Weersink,et al. Photodynamic therapy for urological malignancies: past to current approaches. , 2006, The Journal of urology.
[120] R. Hill. Primary Photoprocesses in Biology and Medicine : by R.V. Bensasson, G. Jori, E.J. Land and T.G. Truscott; Plenum, 1985; 478 pp.; price, $85.00; ISBN 0-306-41930-0 , 1986 .
[121] P. Calzavara-Pinton,et al. Photodynamic therapy: update 2006 Part 2: Clinical results , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[122] W. Sibbett,et al. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy , 2006, The British journal of dermatology.
[123] Hsiung-Lin Tu,et al. In vitro Studies of Functionalized Mesoporous Silica Nanoparticles for Photodynamic Therapy , 2009 .
[124] K. Caca,et al. General principles of photodynamic therapy (PDT) and gastrointestinal applications. , 2004, Current pharmaceutical biotechnology.
[125] N. Kerrouche,et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities , 2008, The British journal of dermatology.
[126] H Stepp,et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[127] J Moan,et al. 5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.
[128] Rik Roelandts,et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. , 2008, European journal of dermatology : EJD.
[129] M. Reed,et al. The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.
[130] E. Jeffes,et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. , 2004, Archives of dermatology.
[131] H. Moseley,et al. Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.
[132] Francisco Sanz-Rodríguez,et al. Photodynamic therapy of cancer. Basic principles and applications , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.